XML 34 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Balance Sheet Components
12 Months Ended
Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components

4. Balance Sheet Components

Cash Equivalents and Available-for-sale Securities

Cash equivalents and available-for-sale securities consisted of the following (in thousands):

 

     December 31, 2016  
     Amortized      Gross Unrealized        
     Cost      Gains      Losses     Fair Value  

Money market funds

   $ 11,270      $ —        $ —       $ 11,270  

Corporate bonds

     21,886        —          (45     21,841  

Commercial paper

     10,769        —          —         10,769  

Government bonds

     41,316        2        (29     41,289  
  

 

 

    

 

 

    

 

 

   

 

 

 

Total cash equivalents and available-for-sale securities

   $ 85,241      $ 2      $ (74   $ 85,169  
  

 

 

    

 

 

    

 

 

   

 

 

 

Classified as:

          

Cash equivalents

           $ 18,504  

Available-for-sale securities - current

             56,515  

Available-for-sale securities - noncurrent

             10,150  
          

 

 

 

Total cash equivalents and available-for-sale securities

           $ 85,169  
          

 

 

 
     December 31, 2015  
     Amortized      Gross Unrealized        
     Cost      Gains      Losses     Fair Value  

Money market funds

   $ 2,136      $ —        $ —       $ 2,136  

Corporate bonds

     7,373        —          (5     7,368  

Commercial paper

     500        —          —         500  
  

 

 

    

 

 

    

 

 

   

 

 

 

Total cash equivalents and available-for-sale securities

   $ 10,009      $ —        $ (5   $ 10,004  
  

 

 

    

 

 

    

 

 

   

 

 

 

Classified as:

          

Cash equivalents

           $ 2,136  

Available-for-sale securities - current

             7,868  
          

 

 

 

Total cash equivalents and available-for-sale securities

           $ 10,004  
          

 

 

 

All available-for-sale securities - current held as of December 31, 2016 and December 31, 2015 had contractual maturities of less than one year. All available securities – noncurrent held as of December 31, 2016 had contractual maturities of greater than one year but less than two years. There have been no material realized gains or losses on available-for-sale securities for the periods presented.

 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

     December 31,  
     2016      2015  

Prepaid clinical and research related expenses

   $ 2,488      $ 1,253  

Other

     906        305  
  

 

 

    

 

 

 

Prepaid expenses and other current assets

   $ 3,394      $ 1,558  
  

 

 

    

 

 

 

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

     December 31,  
     2016      2015  

Laboratory equipment

   $ 1,650      $ 1,452  

Furniture and computer equipment

     163        140  

Leasehold improvements

     62        48  
  

 

 

    

 

 

 

Total property and equipment

     1,875        1,640  

Less: accumulated depreciation and amortization

     (1,313      (1,031
  

 

 

    

 

 

 

Property and equipment, net

   $ 562      $ 609  
  

 

 

    

 

 

 

Depreciation expense for the years ended December 31, 2016, 2015 and 2014 was $317,000, $247,000 and $258,000, respectively. As of December 31, 2016 and 2015, $8,000 and $51,000, respectively, property and equipment, net, were located in Australia. The remainder of the assets are located in the United States.

Accrued Expenses and Other Payables

Accrued expenses and other payables consisted of the following (in thousands):

 

     December 31,  
     2016      2015  

Accrued clinical and research related expenses

   $ 3,617      $ 976  

Accrued employee related expenses

     1,420        754  

Other

     235        149  
  

 

 

    

 

 

 

Total accrued expenses and other payables

   $ 5,272      $ 1,879